Candel Therapeutics, Inc. CADL Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s operating lease liabilities (total)?
- Candel Therapeutics, Inc. (CADL) reported operating lease liabilities (total) of $1.8M in Q1 2026.
- How has Candel Therapeutics, Inc.'s operating lease liabilities (total) changed year-over-year?
- Candel Therapeutics, Inc.'s operating lease liabilities (total) increased by 114.6% year-over-year, from $837K to $1.8M.
- What is the long-term trend for Candel Therapeutics, Inc.'s operating lease liabilities (total)?
- Over 3 years (2022 to 2025), Candel Therapeutics, Inc.'s operating lease liabilities (total) has grown at a -0.8% compound annual growth rate (CAGR), from $1.95M to $1.9M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.